Company Performance Metrics
ANEUVO® is a platform and therapy development company focused on treating disabling injuries and disorders that have not been treated successfully with existing conventional therapies. Our mission is simple: help people living with SCI regain movement, independence, and hope. Spinal cord injuries present life-changing challenges, but innovative
therapies like transcutaneous spinal stimulation are opening new doors.
At ANEUVO, we share a common goal: to help restore functional independence, improve quality of life, and create a healthier, more equitable world for people living with disabling diseases and conditions.
The ANEUVO ExaStim® Stimulation System is an FDA Breakthrough Device Designated non-invasive neuromodulation system created by ANEUVO for the treatment of spinal cord injury. The system recently received CE Mark approval in April of 2025.
